MD2019B2 - Process for obtaining of 8a-acetoxy-14,15-bisnorlabdan-13-one from sclareol diacetate - Google Patents

Process for obtaining of 8a-acetoxy-14,15-bisnorlabdan-13-one from sclareol diacetate Download PDF

Info

Publication number
MD2019B2
MD2019B2 MD20010043A MD20010043A MD2019B2 MD 2019 B2 MD2019 B2 MD 2019B2 MD 20010043 A MD20010043 A MD 20010043A MD 20010043 A MD20010043 A MD 20010043A MD 2019 B2 MD2019 B2 MD 2019B2
Authority
MD
Moldova
Prior art keywords
diacetate
sclareol
bisnorlabdan
acetoxy
obtaining
Prior art date
Application number
MD20010043A
Other languages
Romanian (ro)
Other versions
MD20010043A (en
MD2019C2 (en
Inventor
Pavel Vlad
Aculina Aricu
Elena Barcari
Original Assignee
Inst De Chimie Al Academiei De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst De Chimie Al Academiei De filed Critical Inst De Chimie Al Academiei De
Priority to MDA20010043A priority Critical patent/MD2019C2/en
Publication of MD20010043A publication Critical patent/MD20010043A/en
Publication of MD2019B2 publication Critical patent/MD2019B2/en
Publication of MD2019C2 publication Critical patent/MD2019C2/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a process for obtaining the 8a-acetoxy-14,15-bisnorlabdan-13-one compound from sclareol diacetate, intermediate in the synthesis of compounds with strong amber smell, used in perfumery industry. The process consists in oxidation by ozonation of sclareol diacetate in a methanol and methylene chloride mixture solution at a temperature of -80...+24 degree C, treatment of the ozonation product with a mixture of equivalent amounts of ferrous sulphate heptahydrate and copper diacetate monohydrate at the room temperature, with the subsequent separation and purification of the final product.Claims: 2
MDA20010043A 2001-02-22 2001-02-22 Process for obtaining of 8a-acetoxy-14,15-bisnorlabdan-13-one from sclareol diacetate MD2019C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010043A MD2019C2 (en) 2001-02-22 2001-02-22 Process for obtaining of 8a-acetoxy-14,15-bisnorlabdan-13-one from sclareol diacetate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010043A MD2019C2 (en) 2001-02-22 2001-02-22 Process for obtaining of 8a-acetoxy-14,15-bisnorlabdan-13-one from sclareol diacetate

Publications (3)

Publication Number Publication Date
MD20010043A MD20010043A (en) 2002-09-30
MD2019B2 true MD2019B2 (en) 2002-10-31
MD2019C2 MD2019C2 (en) 2003-04-30

Family

ID=19739757

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010043A MD2019C2 (en) 2001-02-22 2001-02-22 Process for obtaining of 8a-acetoxy-14,15-bisnorlabdan-13-one from sclareol diacetate

Country Status (1)

Country Link
MD (1) MD2019C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4248C1 (en) * 2013-04-19 2014-03-31 Институт Химии Академии Наук Молдовы Process for producing 14,15-bisnorlabdane-8(9)-en-13-one

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4248C1 (en) * 2013-04-19 2014-03-31 Институт Химии Академии Наук Молдовы Process for producing 14,15-bisnorlabdane-8(9)-en-13-one

Also Published As

Publication number Publication date
MD20010043A (en) 2002-09-30
MD2019C2 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
MY134641A (en) Indolinephenylsulphonamide derivatives
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
CA2460939A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
MXPA05010682A (en) Novel compounds.
MXPA04002405A (en) Phenethanolamine derivatives for treatment of respiratory diseases.
TW200519075A (en) Novel compounds
YU82802A (en) Anthranylamides and their use as medicaments
MY109856A (en) Tocotrienols and tocotrienol-like compounds and methods for their use
BG105588A (en) Anthranilic acide amides and the use thereof as medicaments
WO2004037773A8 (en) Phenethanolamine derivative for the treatment of respiratory diseases
TW200505442A (en) Immunosuppressant compounds and compositions
TNSN05294A1 (en) Immunosuppressant compounds and compositions
SI1638551T1 (en) Immunosuppressant compounds and compositions
HK1049333A1 (en) Lactams substituted by cyclic succinates as inhibitors of a-beta protein production
TW200736213A (en) Dicarboxylic acid derivatives and their use
ATE398628T1 (en) OXIDATION PROCESS FOR PRODUCING THE INTERMEDIATE PRODUCT 6.ALPHA.,9.ALPHA.-DIFLUORO-
IL165988A0 (en) Process for the preparation of fibrinogen
BR9908395B1 (en) process of treating the reaction mixture from the direct oxidation of cyclohexane to adipic acid.
FI20011889A0 (en) Process for the preparation of xylitol
MD2019B2 (en) Process for obtaining of 8a-acetoxy-14,15-bisnorlabdan-13-one from sclareol diacetate
MXPA04000310A (en) Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses.
BR9808589A (en) Process for the production of cabbage hexamine nitrate
CA2485298A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
TW200517368A (en) Process
MXPA03004537A (en) Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases.

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees